Clinical trial · Observational
Evaluation by MRI of Anal Canal Cell Carcinoma: is There Predictive Factor?
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Anal canal cell carcinoma is a very rare cancer but well treated. If the morphological test are well established in the initial evaluation, it's not the case of the follow up evaluation particularly by MRI.About 1/3 of patient decline with metastatic relapse during the follow up of these patients.It appears that clinical regression seen precociously is a predictive factor of survival without relapse. But there 's no study confirming that point. This context takes us to evaluate if there is a predictive factor in MRI to final clinical result.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Anal Carcinoma | Anal Carcinoma | ONTOLOGY_EXACT | 0.98 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| MRI sequence | Diagnostic Test | — | UNRESOLVED |
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (3)
- measure
- Distance with regard to the anal margin
- timeFrame
- maximum of 6 years after the initial MRI
- description
- tumor position
- measure
- initial tumor size
- timeFrame
- maximum of 6 years after the initial MRI
- description
- Maximal tumoral size in the cranio-caudal plan in cm
- measure
- presence of nodal status
- timeFrame
- maximum of 6 years after the initial MRI
- description
- presence of nodal status in inguinal region
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * patient with anal canal cell carcinoma histologically proved * patient with initial MRI and follow up MRI in Hospital St Joseph's radiology yard. * patient for whom a radio chemotherapy treatment decision was taken. Exclusion Criteria: * patients with already metastatic lesions
References
Publications (0)
Data not yet available